In the AML cohort, CD69 expression was positively correlated with the immune microenvironment abundance of pro-cancer immune cells, including CD56dim natural killer cells, immature dendritic cells, and MDSCs (Supplementary Figure S2). This evidence concerns the gene CD69 and acute myeloid leukemia.